Flores, Micaiah A.
HRN: 27-07-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2026
CEFUROXIME 750MG (VIAL)
03/22/2026
03/29/2026
IV
240mg
Q8
PCAP-C
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: